program logo/macu/on light

Dry Eye and Dry Macular Degeneration: Is There a Connection?

Joshua Dunaief, MD, PhD

Scheie Eye Institute, University of Pennsylvania

  • Expert Advice
Published on:
dry-eye-and-dry-macular

Dry eye and dry age-related macular degeneration are two conditions that occur more frequently as people age. This article discusses the causes and treatments for dry eye, and whether the condition is related to dry AMD.

What is Dry Eye?

Dry eye develops when the tear film covering the front of the eye drys out.

It occurs most often in the winter, when the air is dry. It can also occur in summer, when a car air conditioner is blowing lots of air into the eyes, causing tear evaporation. This can be uncomfortable, causing a burning sensation and temporarily blurred vision.

The burning sensation in dry eye is caused by stimulation of nerves in the cornea, which are “unhappy” because the cornea needs the tear film for nourishment, lubrication, and anti-microbial defense. This stimulation will sometimes cause a reflexive flood of tears, causing the dry eye patient to temporarily have very wet eyes!

Video: Dry Eye Overview

View Video


View a transcript of the video

What is Age-Related Macular Degeneration (AMD)?

There are two forms of age-related macular degeneration, wet AMD and dry AMD.

Wet AMD
Patients with wet AMD have new blood vessels that grow into the retina, which is in the back of the eye. These vessels can leak and bleed, causing problems. The leakage can often be stopped by intraocular injections of brolucizumab (Beovu®), ranibizumab (Lucenti®), aflibercept (Eylea®), or bevacizumab (Avastin®).

Causes of Dry Eye

Dry eye can have a number of different causes. One is inadequate production of the watery component of tears. Another cause is blockage of the tiny meibomian glands in the eyelids that produce lipids needed to coat the tears and delay their evaporation. A third is inflammation of the ocular surface.

The extreme case of inflammation-associated dry eye is caused by an auto-immune disease called Sjogren’s. Inflammation contributes to dry eye in at least 20 percent of patients, and they may be helped with anti-inflammatory eye drops. Dry eye can also be caused by LASIK surgery, medications for anxiety, Parkinson’s disease, and high blood pressure or by antihistamines, decongestants, antidepressants, and hormone replacement therapy.

Treatment for Dry Eye

Some people develop clogged meibomian glands, which produce an oily substance that prevents evaporation of the eye's tear film. Using a warm, wet washcloth applied to the eye lids for five minutes twice a day can be helpful. Oral doxycycline might also be prescribed by an ophthalmologist to loosen the secretions that are clogging the glands.

Artificial tears can provide temporary relief. The ones that come in single-dose vials are best, because they do not contain potentially irritating preservatives, but they are expensive. Alternatively, many patients like the multi-dose droppers. Artificial tears come in different levels of thickness, with the thicker ones providing longer-lasting relief, but blurring the vision initially. The thicker versions, such as gels or ointments, are best used immediately before bedtime.

Another treatment for dry eye is to block the tiny drains that remove tears from the surface of the eye. These four drains, called puncta, are located in the corners of the eyelids near the nose. They can be blocked temporarily with silicone plugs, or permanently closed with an in-office procedure.

In summary, treatments for dry eye include:

  • Warm, wet washcloth applied to eyelids
  • Medication such as doxycycline
  • “Artificial tears” eye drops
  • Temporary silicone plugs to block puncta
  • In-office treatment to permanently block puncta

Is There a Connection Between Dry AMD and Dry Eye?

While dry eye is common, and can be quite annoying, fortunately it has no connection to dry AMD. There is no evidence that patients with dry eye have an increased risk of dry AMD, or vice versa, although people may have both of these conditions, which are more common in people age 50 and older. Learn about ​treatments for dry macular degeneration​.
 

About the author

dr._joshua_dunaief_new

Joshua Dunaief, MD, PhD

Scheie Eye Institute, University of Pennsylvania

Joshua Dunaief, MD, received his BA magna cum laude in Biology from Harvard (1987), MD/PhD from Columbia College of Physicians and Surgeons (1996), completed ophthalmology residency at the Wilmer Eye Institute, Johns Hopkins in 2000, and medical retina fellowship at Scheie Eye Institute, University of Pennsylvania in 2004.

Help find a cure

Donate to help end Macular Degeneration Disease

I would like to donate

Stay in touch

Receive Macular Degeneration research updates and inspiring stories